# FDA recall D-0460-2023

> **Breckenridge Pharmaceutical, Inc** · Class II · drug recall initiated 2023-03-02.

## Product

Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC 51991-0706-05) and c) 1,000-count bottle (NDC 51991-0706-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.

## Reason for recall

CGMP Deviations: Potential risk of Cross Contamination

## Distribution

USA nationwide.

## Key facts

- **Recall number:** D-0460-2023
- **Recalling firm:** Breckenridge Pharmaceutical, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-03-02
- **Report date:** 2023-03-22
- **Termination date:** 2024-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Berlin, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0460-2023

## Citation

> AI Analytics. FDA recall D-0460-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0460-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*